ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Parotid gland enlargement,Salivary gland enlargements,Salivary gland conditions,Gastr,N
1,2,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
3,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
5,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
6,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
7,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
8,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
8,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8,3,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
9,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
9,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
9,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
9,4,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
9,5,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
9,6,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
9,7,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
10,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
12,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
12,2,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
12,3,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
12,4,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
13,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
14,1,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
15,1,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
16,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
16,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
17,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
18,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
19,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
19,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
20,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
21,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
22,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
23,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
24,1,Procedural pain,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
25,1,Procedural pain,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
26,1,Procedural pain,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
27,1,Atrioventricular block second degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
27,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
28,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
29,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
30,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
31,1,Cholinergic syndrome,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
31,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
32,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
32,2,Micturition disorder,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
33,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
34,1,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
35,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
35,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
36,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
37,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
38,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
39,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
40,1,Extrasystoles,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
41,1,Extrasystoles,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
42,1,Pyloric stenosis,Gastric disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
43,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
43,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
44,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
45,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
46,1,Anastomotic complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
47,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
47,2,Conversion disorder,Somatic symptom disorders,Somatic symptom and related disorders,Psych,N
48,1,Venous thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
49,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
50,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
50,2,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
50,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
51,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
51,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
52,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
52,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
52,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
52,4,Gastrointestinal anastomotic leak,Gastrointestinal and hepatobiliary procedural complications,Procedural related injuries and complications NEC,Inj&P,N
52,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
52,6,Shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
52,7,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
53,1,Delayed recovery from anaesthesia,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
53,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
54,1,Delayed recovery from anaesthesia,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
54,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
55,1,Delayed recovery from anaesthesia,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
55,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
56,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
57,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
58,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
58,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
58,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
58,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
59,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
60,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
60,2,Headache,Headaches NEC,Headaches,Nerv,N
60,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
61,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
61,2,Laryngospasm,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
61,3,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
61,4,Ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
62,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
62,2,Laryngospasm,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
62,3,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
63,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
63,2,Oculogyric crisis,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
64,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
64,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
64,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
65,1,Postoperative thrombosis,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
66,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
67,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
68,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
69,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
69,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
70,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
70,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
71,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
71,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
72,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
72,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
73,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
73,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
73,3,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
74,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
74,2,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
74,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
75,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
75,2,Postoperative respiratory failure,Respiratory tract and thoracic cavity procedural complications,Procedural related injuries and complications NEC,Inj&P,N
76,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
76,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
77,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
77,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
78,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
78,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
79,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
79,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
79,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
80,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
80,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
80,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
81,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
81,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
81,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
82,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
82,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
82,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
83,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
